HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity-Reference-Cited by-同舟云学术

HFE Gene Variants' Impact on Anthracycline-Based Chemotherapy-Induced Subclinical Cardiotoxicity

Published:2020-08-03 Issue:1 Volume:21 Page:59-66
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Vaitiekus Domas^ORCID,Muckiene Gintare,Vaitiekiene Audrone,Sereikaite Liveta,Inciuraite Ruta,Insodaite Ruta,Cepuliene Daiva,Kupcinskas Juozas,Ugenskiene Rasa,Jurkevicius Renaldas,Juozaityte Elona

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s12012-020-09595-1.pdf

Reference36 articles.

1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21492.

2. Curigliano, G., Cardinale, D., Suter, T., et al. (2012). Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Annals of Oncology. https://doi.org/10.1093/annonc/mds293.

3. Rygiel, K. (2016). Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials. Indian Journal of Pharmacology. https://doi.org/10.4103/0253-7613.190719.

4. Afifi, A. M., Saad, A. M., Al-Husseini, M. J., Elmehrath, A. O., Northfelt, D. W., & Sonbol, M. B. (2020). Causes of death after breast cancer diagnosis: A US population-based analysis. Cancer, 126(7), 1559–1567. https://doi.org/10.1002/cncr.32648.

5. Szmit, S., Jurczak, W., Zaucha, J. M., Drozd-Sokołowska, J., Spychałowicz, W., Joks, M., et al. (2014). Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma. Journal of the American Society of Hypertension, 8(11), 791–799.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron metabolism in doxorubicin-induced cardiotoxicity: From mechanisms to therapies;The International Journal of Biochemistry & Cell Biology;2024-09

2. Genetic factors in the pathogenesis of cardio-oncology;Journal of Translational Medicine;2024-08-05

3. Ferroptosis: Latest evidence and perspectives on plant‐derived natural active compounds mitigating doxorubicin‐induced cardiotoxicity;Journal of Applied Toxicology;2024-07-18

4. Molecular Mechanisms and Therapeutic Targeting of Ferroptosis in Doxorubicin-Induced Cardiotoxicity;JACC: Basic to Translational Science;2024-06

5. T1 Mapping in Cardiovascular Magnetic Resonance—A Marker of Diffuse Myocardial Fibrosis in Patients Undergoing Hematopoietic Stem Cell Transplantation;Journal of Personalized Medicine;2024-04-13